Evidence map›Paper›PMID 31942789›Full record

ArticleBiochemistry2020

Metastable HIV-1 Surface Protein Env Sensitizes Cell Membranes to Transformation and Poration by Dual-Acting Virucidal Entry Inhibitors.

Charles G Ang, Md Alamgir Hossain, Marg Rajpara, Harry Bach, Kriti Acharya, Alexej Dick, Adel A Rashad, Michele Kutzler, Cameron F Abrams, Irwin Chaiken

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Charles G AngDepartment of Biochemistry and Molecular Biology, College of Medicine , Drexel University , Philadelphia , Pennsylvania 19102 , United States.ORCID 0000-0002-2368-552X
Md Alamgir HossainDepartment of Biochemistry and Molecular Biology, College of Medicine , Drexel University , Philadelphia , Pennsylvania 19102 , United States.
Marg RajparaDepartment of Biochemistry and Molecular Biology, College of Medicine , Drexel University , Philadelphia , Pennsylvania 19102 , United States.
Harry BachDepartment of Biochemistry and Molecular Biology, College of Medicine , Drexel University , Philadelphia , Pennsylvania 19102 , United States.
Kriti AcharyaDepartment of Biochemistry and Molecular Biology, College of Medicine , Drexel University , Philadelphia , Pennsylvania 19102 , United States.ORCID 0000-0002-3408-149X
Alexej DickDepartment of Biochemistry and Molecular Biology, College of Medicine , Drexel University , Philadelphia , Pennsylvania 19102 , United States.
Adel A RashadDepartment of Biochemistry and Molecular Biology, College of Medicine , Drexel University , Philadelphia , Pennsylvania 19102 , United States.ORCID 0000-0001-6113-0333
Michele KutzlerDepartment of Microbiology and Immunology, College of Medicine , Drexel University , Philadelphia , Pennsylvania 19102 , United States.ORCID 0000-0001-5692-5617
Cameron F AbramsDepartment of Chemical and Biological Engineering, College of Engineering , Drexel University , Philadelphia , Pennsylvania 19104 , United States.ORCID 0000-0002-1240-0816
Irwin ChaikenDepartment of Biochemistry and Molecular Biology, College of Medicine , Drexel University , Philadelphia , Pennsylvania 19102 , United States.
Drexel University · US

Funding

Understanding Envelope Function in HIV-1 Infection: The Design, Synthesis and Validation of Small Molecule HIV-1 Env InhibitorsP01AI150471 · NIAID · DREXEL UNIVERSITY · PI HENDRICKSON, WAYNE A. · 2019 to 2022
$7.8M
Interdisciplinary And Translational Research Training In NeurohivT32MH079785 · NIMH · TEMPLE UNIV OF THE COMMONWEALTH · PI Kamel Khalili · 2008 to 2026
$5.4M
Dual-action virolytic entry inhibitors against HIV-1R01GM115249 · NIGMS · DREXEL UNIVERSITY · PI ABRAMS, CAMERON F, CHAIKEN, IRWIN M · 2015 to 2018
$2.0M
NIAID NIH HHS P01 AI150471NIGMS NIH HHS R01 GM115249NIMH NIH HHS T32 MH079785
6 · The paper itself

Abstract

Dual-acting virucidal entry inhibitors (DAVEIs) have previously been shown to cause irreversible inactivation of HIV-1 Env-presenting pseudovirus by lytic membrane transformation. This study examined whether this transformation could be generalized to include membranes of Env-presenting cells. Flow cytometry was used to analyze HEK293T cells transiently transfected with increasing amounts of DNA encoding JRFL Env, loaded with calcein dye, and treated with serial dilutions of microvirin (Q831K/M83R)-DAVEI. Comparing calcein retention against intact Env expression (via Ab 35O22) on individual cells revealed effects proportional to Env expression. "Low-Env" cells experienced transient poration and calcein leakage, while "high-Env" cells were killed. The cell-killing effect was confirmed with an independent mitochondrial activity-based cell viability assay, showing dose-dependent cytotoxicity in response to DAVEI treatment. Transfection with increasing quantities of Env DNA showed further shifts toward "High-Env" expression and cytotoxicity, further reinforcing the Env dependence of the observed effect. Controls with unlinked DAVEI components showed no effect on calcein leakage or cell viability, confirming a requirement for covalently linked DAVEI compounds to achieve Env transformation. These data demonstrate that the metastability of Env is an intrinsic property of the transmembrane protein complex and can be perturbed to cause membrane disruption in both virus and cell contexts.

Indexed as

Amino Acid SequenceBacterial ProteinsCell Membraneenv Gene Products, Human Immunodeficiency VirusHEK293 CellsHIV Fusion InhibitorsHumansMannose-Binding LectinProtein StabilityProtein Structure, SecondaryVirus InternalizationBacterial Proteinsenv Gene Products, Human Immunodeficiency VirusHIV Fusion InhibitorsMannose-Binding Lectinmicrovirin protein, Microcystis aeruginosa

Identifiers

PMID31942789
PMCPMC7362902
OpenAlexW2999379341

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.